Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrin S Reiners

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicityBoris Böll, Farag Eltaib, Katrin S Reiners, et al.
Journal of Extracellular Vesicles|April 17, 2019
Extracellular vesicle measurements with nanoparticle tracking analysis - An accuracy and repeatability comparison between NanoSight NS300 and ZetaViewDaniel Bachurski, Maximiliane Schuldner, Phuong-Hien Nguyen, et al.
Blood|October 8, 2005
A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivoElke Pogge von Strandmann, Hinrich P Hansen, Katrin S Reiners, et al.
Molecular Cancer Therapeutics|April 29, 2011
Induction of in vitro and in vivo NK cell cytotoxicity using high-avidity immunoligands targeting prostate-specific membrane antigen in prostate carcinomaRon D Jachimowicz, Giulio Fracasso, Paul J Yazaki, et al.
Cancer Research|January 11, 2007
ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitroDennis A Eichenauer, Vijaya Lakshmi Simhadri, Elke Pogge von Strandmann, et al.
Blood|March 20, 2013
Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activityKatrin S Reiners, Daniela Topolar, Alexander Henke, et al.
Cell Communication and Signaling : CCS|October 6, 2023
Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesiclesAlexandra Brahmer, Carsten Geiß, Andriani Lygeraki, et al.
Immunity|December 7, 2007
Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cellsElke Pogge von Strandmann, Venkateswara Rao Simhadri, Bastian von Tresckow, et al.
Cardiovascular Research|November 2, 2020
MicroRNA-mediated vascular intercellular communication is altered in chronic kidney diseaseAndreas Zietzer, Eva Steffen, Sven Niepmann, et al.
Oncoimmunology|November 18, 2016
RIG-I activation induces the release of extracellular vesicles with antitumor activityJuliane Daßler-Plenker, Katrin S Reiners, Jasper G van den Boorn, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicityBoris Böll, Farag Eltaib, Katrin S Reiners, et al.
Journal of Extracellular Vesicles|April 17, 2019
Extracellular vesicle measurements with nanoparticle tracking analysis - An accuracy and repeatability comparison between NanoSight NS300 and ZetaViewDaniel Bachurski, Maximiliane Schuldner, Phuong-Hien Nguyen, et al.
Blood|October 8, 2005
A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivoElke Pogge von Strandmann, Hinrich P Hansen, Katrin S Reiners, et al.
Molecular Cancer Therapeutics|April 29, 2011
Induction of in vitro and in vivo NK cell cytotoxicity using high-avidity immunoligands targeting prostate-specific membrane antigen in prostate carcinomaRon D Jachimowicz, Giulio Fracasso, Paul J Yazaki, et al.
Cancer Research|January 11, 2007
ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitroDennis A Eichenauer, Vijaya Lakshmi Simhadri, Elke Pogge von Strandmann, et al.
Blood|March 20, 2013
Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activityKatrin S Reiners, Daniela Topolar, Alexander Henke, et al.
Cell Communication and Signaling : CCS|October 6, 2023
Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesiclesAlexandra Brahmer, Carsten Geiß, Andriani Lygeraki, et al.
Immunity|December 7, 2007
Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cellsElke Pogge von Strandmann, Venkateswara Rao Simhadri, Bastian von Tresckow, et al.
Cardiovascular Research|November 2, 2020
MicroRNA-mediated vascular intercellular communication is altered in chronic kidney diseaseAndreas Zietzer, Eva Steffen, Sven Niepmann, et al.
Oncoimmunology|November 18, 2016
RIG-I activation induces the release of extracellular vesicles with antitumor activityJuliane Daßler-Plenker, Katrin S Reiners, Jasper G van den Boorn, et al.
Pageof 5